Predictive Clinical and Biological Parameters in Gynecological Cancer

NCT ID: NCT01977274

Last Updated: 2020-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2033-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cancer Endometrium Cancer Cervix Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

gynecological cancer

blood and tumor samples

Group Type EXPERIMENTAL

gynecological cancer

Intervention Type OTHER

blood and tumor samples

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gynecological cancer

blood and tumor samples

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* gynecological cancer suspicion
* age \> 18
* signed informed consent

Exclusion Criteria

\- emergency
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Paoli-Calmettes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Paoli Calmettes

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dominique GENRE, MD

Role: CONTACT

33491223778

Margot BERLINE, MSc, MBA

Role: CONTACT

33491223778

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dominique GENRE, MD

Role: primary

33491223778

Margot BERLINE, MSc, MBA

Role: backup

33491223778

Related Links

Access external resources that provide additional context or updates about the study.

http://www.institutpaolicalmettes.fr

official web site of the sponsor

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GC-BIO-IPC 2013-010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.